These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32626347)

  • 21. Safety and efficacy of EB15 10 (
    ; Rychen G; Aquilina G; Azimonti G; Bampidis V; Bastos ML; Bories G; Chesson A; Cocconcelli PS; Flachowsky G; Gropp J; Kolar B; Kouba M; López-Alonso M; López Puente S; Mantovani A; Mayo B; Ramos F; Villa RE; Wallace RJ; Wester P; Brozzi R; Saarela M
    EFSA J; 2018 Apr; 16(4):e05199. PubMed ID: 32625859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Fašmon Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf B; Herman L; Prieto Maradona M; Saarela M; Brozzi R; Galobart J; Gregoretti L; López-Gálvez G; Vettori MV; Innocenti ML; Sofianidis K
    EFSA J; 2020 Nov; 18(11):e06280. PubMed ID: 33204311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of a feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Galobart J; Vettori MV; Brozzi R
    EFSA J; 2021 Nov; 19(11):e06903. PubMed ID: 34765040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of the feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Saarela M; Brozzi R; Galobart J; Pettenati E; Revez J
    EFSA J; 2021 Jun; 19(6):e06620. PubMed ID: 34140993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the application for renewal of the authorisation of Calsporin
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf B; Herman L; Maradona MP; Saarela M; Anguita M; Galobart J; Holczknecht O; Manini P; Pizzo F; Tarrés-Call J; Pettenati E
    EFSA J; 2020 Nov; 18(11):e06283. PubMed ID: 33209150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of a feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Fašmon Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Brantom P; Maradona MP; Anguita M; Galobart J; Pettenati E; Revez J
    EFSA J; 2022 Feb; 20(2):e07152. PubMed ID: 35237356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Durjava M; Dusemund B; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M; Ortuño J; Revez J; Navarro-Villa A
    EFSA J; 2023 Jun; 21(6):e08053. PubMed ID: 37304354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of Correlink™ ABS1781
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Fašmon Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf B; Prieto Maradona M; Saarela M; Galobart J; Gregoretti L; Innocenti M; López-Gálvez G; Pettenati E; Revez J; Sofianidis K; Tarrés J; Vettori MV; Brozzi R
    EFSA J; 2020 Nov; 18(11):e06279. PubMed ID: 33204310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of Alterion NE
    ; Rychen G; Aquilina G; Azimonti G; Bampidis V; Bastos ML; Bories G; Chesson A; Cocconcelli PS; Flachowsky G; Gropp J; Kolar B; Kouba M; López-Alonso M; López Puente S; Mantovani A; Mayo B; Ramos F; Villa RE; Wallace RJ; Wester P; Brozzi R; Saarela M
    EFSA J; 2017 Jul; 15(7):e04933. PubMed ID: 32625589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of EB15 10 (
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M
    EFSA J; 2019 Nov; 17(11):e05882. PubMed ID: 32626170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of Levucell
    ; Bampidis V; Azimonti G; Bastos M; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa R; Woutersen R; Brozzi R
    EFSA J; 2019 Jan; 17(1):e05535. PubMed ID: 32626080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of Correlink™ ABS747
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Fašmon Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Glandorf B; Prieto Maradona M; Saarela M; Galobart J; Gregoretti L; Innocenti M; López-Gálvez G; Pettenati E; Pizzo F; Revez J; Sofianidis K; Vettori MV; Brozzi R
    EFSA J; 2020 Nov; 18(11):e06278. PubMed ID: 33204309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the application for modification of the terms of the authorisation of the feed additive consisting of
    ; Bampidis V; Azimonti G; de Lourdes Bastos M; Christensen H; Dusemund B; Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Prieto Maradona M; Anguita M; Galobart J; Pettenati E; Brozzi R; Alija Novo N
    EFSA J; 2023 Aug; 21(8):e08179. PubMed ID: 37583945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of the feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Durjava MF; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Cocconcelli PS; Dierick N; Glandorf B; Martelli G; Maradona MP; Saarela M; Galobart J; Gregoretti L; Innocenti ML; López-Gálvez G; Revez J; Vettori MV; Brozzi R
    EFSA J; 2021 Mar; 19(3):e06449. PubMed ID: 33732395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of a feed additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Edoardo Villa R; Woutersen R; Anguita M; Galobart J; Ortuño J; Vittoria Vettori M; Brozzi R
    EFSA J; 2022 Jan; 20(1):e06984. PubMed ID: 35058989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of an additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Brozzi R; Galobart J; Pettenati E; Revez J; Innocenti ML
    EFSA J; 2021 Apr; 19(4):e06523. PubMed ID: 33897862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of an additive consisting of
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Brozzi R; Galobart J; Pettenati E; Revez J; Innocenti ML
    EFSA J; 2021 Apr; 19(4):e06524. PubMed ID: 33897863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of Levucell
    ; Bampidis V; Azimonti G; de Lourdes Bastos M; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Anguita M; Galobart J; Holczknecht O; Manini P; Tarrés-Call J; Pettenati E; Pizzo F
    EFSA J; 2019 Apr; 17(4):e05693. PubMed ID: 32626297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of Probion forte
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Glandorf B; Herman L; Prieto Maradona M; Saarela M; Anguita M; Brozzi R; Galobart J; Holczknecht O; Manini P; Tarrès-Call J; Pettenati E; Pizzo F
    EFSA J; 2019 Mar; 17(3):e05644. PubMed ID: 32626265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of Calsporin
    ; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Kouba M; Kos Durjava M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Brozzi R; Galobart J; López-Gálvez G; Gregoretti L; Vettori MV; Innocenti ML
    EFSA J; 2019 Mar; 17(3):e05605. PubMed ID: 32626240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.